Heron Therapeutics Inc (HRTX)
1.07
+0.01
(+0.94%)
USD |
NASDAQ |
Nov 22, 16:00
1.07
0.00 (0.00%)
After-Hours: 18:38
Heron Therapeutics Gross Profit Margin (Quarterly): 71.17% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 71.17% |
| June 30, 2024 | 70.80% |
| March 31, 2024 | 75.64% |
| December 31, 2023 | 71.12% |
| September 30, 2023 | 42.08% |
| June 30, 2023 | 36.53% |
| March 31, 2023 | 43.09% |
| December 31, 2022 | 57.95% |
| September 30, 2022 | 44.58% |
| June 30, 2022 | 41.46% |
| March 31, 2022 | 51.59% |
| December 31, 2021 | 47.03% |
| September 30, 2021 | 51.14% |
| June 30, 2021 | 35.29% |
| March 31, 2021 | 54.01% |
| December 31, 2020 | 54.42% |
| September 30, 2020 | 64.09% |
| June 30, 2020 | 60.27% |
| March 31, 2020 | 58.18% |
| December 31, 2019 | 54.75% |
| September 30, 2019 | 59.66% |
| June 30, 2019 | 62.93% |
| March 31, 2019 | 52.65% |
| December 31, 2018 | 59.88% |
| September 30, 2018 | 61.71% |
| Date | Value |
|---|---|
| June 30, 2018 | 69.72% |
| March 31, 2018 | 72.91% |
| December 31, 2017 | 86.69% |
| September 30, 2017 | 87.74% |
| June 30, 2017 | 88.10% |
| March 31, 2017 | 67.35% |
| December 31, 2016 | 97.26% |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
35.29%
Minimum
Jun 2021
75.64%
Maximum
Mar 2024
54.26%
Average
54.21%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Journey Medical Corp | 63.87% |
| NovaBay Pharmaceuticals Inc | 65.26% |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -12.61% |
| Return on Invested Capital | -20.08% |
| Profit Margin (Quarterly) | -14.78% |
| Operating Margin (Quarterly) | -13.59% |
| Return on Net Operating Assets | -21.16% |